Stock Events

Stock Events

Cumberland Pharmaceuticals 

$6.79
17
+$0.04+0.59% Friday 20:00
+$0.13+1.98%Friday 23:59After hours

Statistics

Day High
6.85
Day Low
6.85
52W High
9.28
52W Low
1.85
Volume
533
Avg. Volume
-
Mkt Cap
101.74M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 26
$1.50
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

10NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.13
-0.03
0.06
0.16
Expected EPS
N/A
Actual EPS
N/A

Financials

-6.37%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
44.52MRevenue
-2.84MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CPIX. It's not an investment recommendation.
Microsoft
5
MSFT
Tesla
4
TSLA
Amazon
4
AMZN
NVIDIA
4
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Jazz Pharmaceuticals
JAZZ
Mkt Cap15.87B
Jazz Pharmaceuticals has a diverse portfolio in areas like pain management and psychiatry, overlapping with Cumberland's focus areas.
Amphastar Pharmaceuticals
AMPH
Mkt Cap936.26M
Amphastar Pharmaceuticals manufactures and sells injectable and inhalation products, competing in the same market as some of Cumberland's offerings.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a large generic and specialty pharmaceutical company that competes across a broad range of product lines, including areas targeted by Cumberland.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc., through its broad range of pharmaceutical products, competes in several therapeutic areas covered by Cumberland.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is a global pharmaceutical giant with a diverse product portfolio that includes areas of focus similar to Cumberland's, such as infectious disease and pain management.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. operates in many of the same therapeutic areas as Cumberland, including pain management and gastroenterology, with a strong emphasis on research and development.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb Company offers a wide range of prescription pharmaceuticals in several therapeutic areas, including those targeted by Cumberland, making them a competitor.

About

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
Show more...
CEO
A. J. Kazimi
Employees
93
Country
United States
ISIN
US2307701092

Listings

XNAS
US
CPIX
BOATS
BOATS
CPIX.BOATS

0 Comments

Share your thoughts

FAQ

What is Cumberland Pharmaceuticals stock price today?▼
The current price of CPIX is $6.79 USD — it has increased by +0.59% in the past 24 hours. Watch Cumberland Pharmaceuticals stock price performance more closely on the chart.
What is Cumberland Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Cumberland Pharmaceuticals stocks are traded under the ticker CPIX.
Is Cumberland Pharmaceuticals stock price growing?▼
CPIX stock has fallen by -19.74% compared to the previous week, the month change is a -10.07% fall, over the last year Cumberland Pharmaceuticals has showed a +105.14% increase.
What is Cumberland Pharmaceuticals market cap?▼
Today Cumberland Pharmaceuticals has the market capitalization of 101.74M
When is the next Cumberland Pharmaceuticals earnings date?▼
Cumberland Pharmaceuticals is going to release the next earnings report on November 10, 2026.
What is Cumberland Pharmaceuticals revenue for the last year?▼
Cumberland Pharmaceuticals revenue for the last year amounts to 44.52M USD.
What is Cumberland Pharmaceuticals net income for the last year?▼
CPIX net income for the last year is -2.84M USD.
Does Cumberland Pharmaceuticals pay dividends?▼
Yes, CPIX dividends are paid en. The last dividend per share was 1.5 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Cumberland Pharmaceuticals have?▼
As of September 05, 2026, the company has 93 employees.
In which sector is Cumberland Pharmaceuticals located?▼
Cumberland Pharmaceuticals operates in the Health & Wellness sector.
When did Cumberland Pharmaceuticals complete a stock split?▼
Cumberland Pharmaceuticals has not had any recent stock splits.
Where is Cumberland Pharmaceuticals headquartered?▼
Cumberland Pharmaceuticals is headquartered in NASHVILLE,, United States.